首页 | 本学科首页   官方微博 | 高级检索  
     

羧基肽酶-H抗体对成人隐匿性自身免疫糖尿病的诊断意义
引用本文:杨琳,周智广,黄干,颜湘,金萍,王建平,李霞,William Hagopian. 羧基肽酶-H抗体对成人隐匿性自身免疫糖尿病的诊断意义[J]. 中国糖尿病杂志, 2003, 11(1): 20-25
作者姓名:杨琳  周智广  黄干  颜湘  金萍  王建平  李霞  William Hagopian
作者单位:[1]中南大学湘雅二医院内分泌科代谢内分泌研究所,长沙410011 [2]华盛顿大学代谢内分泌营养科西北太平洋研究所,长沙410011
基金项目:国家自然科学基金 (39370 343),卫生部优秀青年科技人才基金(Q942 0 ),湖南省卫生厅重点科研基金(9736,2001 Z0 4 ),美国礼来亚洲公司科研基金(72 82 /B5K GH 0 4 35)
摘    要:
目的 探讨羧基肽酶—H自身抗体(CPH—Ab)阳性的2型糖尿病(T2DM)患者的临床特征及该抗体对成人隐匿性自身免疫糖尿病(LADA)的诊断价值。方法 选择临床初诊为T2DM患者545例,1型糖尿病(T1DM)患者85例,健康对照123例进行CPH—Ab测定,同时检测T2DM患者谷氨酸脱羧酶抗体(GAD—Ab)。比较各组CPH—Ab的阳性率以及T2DM中依据CPH—Ab、GAD—Ab划分的3组患者的临床特点。采用放射免疫沉淀法检测CPH—Ab和GAD—Ab。结果 CPH—Ab阳性率在T2DM患者(5.5%,30/545)高于T1DM患者(0%,0/85)和正常对照(0.8%,1/123)(P<0.05),30例CPH—Ab阳性的T2DM患者只有1例同时GAD—Ab阳性。CPH—Ab在低体重(BMI<21kg/m^2)者中的阳性率较高,且该抗体阳性的患者具有起病年龄跨度大、病程较长、低体重、易发生酮症等特点,其空腹C肽介于GAD—Ab阳性与两种抗体(GAD—Ab和CPH—Ab)均阴性的T2DM患者之间,反映代谢综合征的指标水平较低(包括较低的BMI、血压和甘油三酯),而周围神经病变的比例较高。结论 CPH—Ab阳性糖尿病患者的临床特点介于经典的LADA(GAD—Ab阳性)与T2DM患者间。CPH抗体检测是LADA诊断的一项新指标。

关 键 词:羧基肽酶-H抗体 隐匿性自身免疫性 糖尿病 诊断

Carboxypeptidase-H antibody assay for the diagnosis of latent autoimmune diabetes in adults
William Hagopian. Carboxypeptidase-H antibody assay for the diagnosis of latent autoimmune diabetes in adults[J]. Chinese Journal of Diabetes, 2003, 11(1): 20-25
Authors:William Hagopian
Abstract:
Objective To explore the clinical characteristics of type 2 diabetic patients with carboxypeptidase H antibody (CPH Ab) and to disclose the value of CPH Ab in the diagnosis of latent autoimmune diabetes in adults (LADA). Methods We screened 545 patients with initially diagnosed type 2 diabetes mellitus (T2DM), 85 type 1 diabetic (T1DM) patients and 123 healthy controls for CPH Ab assay, and also GAD Ab assay for the T2DM group. T2DM patients were divided into 3 groups according to CPH Ab and GAD Ab to compare the clinical characteristics of them. CPH Ab and GAD Ab were detected with RIA. Results The prevalence of CPH Ab in T2DM (5.5% ,30/545) was higher than that of T1DM patients(0%,0/85; P <0.05) and healthy controls (0.8%, 1/123; P< 0.05). Only 1 was GAD Ab positive in 30 type 2 diabetics with positive CPH Ab. The positivity of CPH Ab was more higher in patients with lower body weight (BMI<21 kg/m 2), and the patients with CPH Ab had a wider range of age at onset, longer duration of disease, lower body mass index and more tendency to develop ketosis. Their fasting C peptide level was between those of the patients with GAD Ab and the patients without any antibody (GAD Ab and CPH Ab), and these patients had less metabolic syndrome (including lower levels of BMI, hypertension percentage and serum triglyceride) and more peripheral neuropathy. Conclusion The clinical characteristics of patients with CPH Ab are between that of classical LADA who is GAD Ab positive and T2DM patients. CPH Ab was a new autoimmune marker for the diagnosis of LADA.
Keywords:Diabetes  Immunity  Diagnosis
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号